Thursday, January 14, 2010

Whitehead Institute - Chimp and human Y chromosomes evolving faster than expected

Whitehead Institute - Chimp and human Y chromosomes evolving faster than expected: "Contrary to a widely held scientific theory that the mammalian Y chromosome is slowly decaying or stagnating, new evidence suggests that in fact the Y is actually evolving quite rapidly through continuous, wholesale renovation.

By conducting the first comprehensive interspecies comparison of Y chromosomes, Whitehead Institute researchers have found considerable differences in the genetic sequences of the human and chimpanzee Ys—an indication that these chromosomes have evolved more quickly than the rest of their respective genomes over the 6 million years since they emerged from a common ancestor. The findings are published online this week in the journal Nature."

Friday, January 01, 2010

Scientists Report Findings on Origin of a Cancer in Tasmanian Devils - NYTimes.com

Scientists Report Findings on Origin of a Cancer in Tasmanian Devils - NYTimes.com: "A team of Australian and American scientists has now followed up on Dr. Belov’s study, using more powerful gene-sequencing technology to take a closer look at a larger number of Tasmanian devils. To trace the origin of the tumors, the scientists looked at individual cancer cells, recording which genes were active. They found a set of genes normally active only in a type of nerve cell known as Schwann cells. They argue that a single Schwann cell in a single animal was the progenitor of all the devil facial tumor disease cells.

“The lack of genetic variation suggests that the tumors are young,” said a co-author of the study, Tony Pappenfuss, a bioinformatician at the Walter and Eliza Hall Institute of Medical Research in Australia.

Scientists have found only one other case in which cancer cells naturally spread like parasites, a disease in dogs known as canine transmissible venereal tumor. Comparisons of tumors collected from dogs around the world indicate that they descend from a single ancestral cell that existed several thousand years ago. Ever since, the tumor cells have evolved to move among hosts and avoid their immune systems."

BBC News - 'Lifeless' prion proteins are 'capable of evolution'

BBC News - 'Lifeless' prion proteins are 'capable of evolution': "Scientists have shown for the first time that 'lifeless' prion proteins, devoid of all genetic material, can evolve just like higher forms of life.
The Scripps Research Institute in the US says the prions can change to suit their environment and go on to develop drug resistance.
Prions are associated with 20 different brain diseases in humans and animals.
The scientists say their work suggests new approaches might be necessary to develop therapies for these diseases."

Cancer Drug Delays Aging in Mice | Wired Science | Wired.com

Cancer Drug Delays Aging in Mice | Wired Science | Wired.com: "In a potentially landmark study on the biology of aging and how to delay it, a drug gave elderly mice the human equivalent of thirteen extra years of life.

Though the drug is an immune system suppressant that almost certainly won’t have the same effect in humans, the study provides compelling evidence that pharmacologically slowing the process of aging itself may be possible."

#61: Child Abuse Leaves Its Mark on Victim’s DNA | Mental Health | DISCOVER Magazine

#61: Child Abuse Leaves Its Mark on Victim’s DNA | Mental Health | DISCOVER Magazine: "Childhood trauma may leave a lasting imprint not just on the psyche but also in the DNA. This news comes from McGill University and the Suicide Brain Bank, a Quebec-based organization that carried out autopsies on suicide victims who had been abused as kids. Across the board, their brains showed DNA modifications that made them particularly sensitive to stress. Although gene variations are primarily inherited at conception, the findings show that environmental impacts can also introduce them later on. “The idea that abuse changes how genes function opens a new window for behavioral and drug therapy,” says study leader and neuroscientist Patrick McGowan."